Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis.

Dai J, Escara-Wilke J, Keller JM, Jung Y, Taichman RS, Pienta KJ, Keller ET.

J Exp Med. 2019 Sep 23. pii: jem.20190158. doi: 10.1084/jem.20190158. [Epub ahead of print]

PMID:
31548301
2.

Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.

Cackowski FC, Wang Y, Decker JT, Sifuentes C, Weindorf S, Jung Y, Wang Y, Decker AM, Yumoto K, Szerlip N, Buttitta L, Pienta KJ, Morgan TM, Taichman RS.

Prostate. 2019 Oct;79(14):1715-1727. doi: 10.1002/pros.23896. Epub 2019 Aug 26.

PMID:
31449673
3.

Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer.

Chung JS, Wang Y, Henderson J, Singhal U, Qiao Y, Zaslavsky AB, Hovelson DH, Spratt DE, Reichert Z, Palapattu GS, Taichman RS, Tomlins SA, Morgan TM.

Neoplasia. 2019 Aug;21(8):802-809. doi: 10.1016/j.neo.2019.06.002. Epub 2019 Jul 2.

4.

Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.

Lee CH, Decker AM, Cackowski FC, Taichman RS.

Cell Biol Toxicol. 2019 Jun 27. doi: 10.1007/s10565-019-09483-7. [Epub ahead of print] Review.

PMID:
31250347
5.

Anticancer polymers designed for killing dormant prostate cancer cells.

Takahashi H, Yumoto K, Yasuhara K, Nadres ET, Kikuchi Y, Taichman RS, Kuroda K.

Sci Rep. 2019 Jan 31;9(1):1096. doi: 10.1038/s41598-018-36608-5.

6.

Minimal Residual Disease in Prostate Cancer.

Cackowski FC, Taichman RS.

Adv Exp Med Biol. 2018;1100:47-53. doi: 10.1007/978-3-319-97746-1_3. Review.

PMID:
30411259
7.

Determining Competitive Potential of Bone Metastatic Cancer Cells in the Murine Hematopoietic Stem Cell Niche.

Park SH, Eber MR, Taichman RS, Shiozawa Y.

Methods Mol Biol. 2019;2002:141-150. doi: 10.1007/7651_2018_178.

PMID:
30099699
8.

Periodontal Treatment in Cancer Patients: An Interdisciplinary Approach.

Decker AM, Taichman LS, D'Silva NJ, Taichman RS.

Curr Oral Health Rep. 2018 Mar;5(1):7-12. Epub 2018 Jan 27.

9.

Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.

Cackowski FC, Taichman RS.

Bone. 2019 Feb;119:82-86. doi: 10.1016/j.bone.2018.02.025. Epub 2018 Feb 26. Review.

PMID:
29496517
10.

Dural Cells Release Factors Which Promote Cancer Cell Malignancy and Induce Immunosuppressive Markers in Bone Marrow Myeloid Cells.

Szerlip NJ, Calinescu A, Smith E, Tagett R, Clines KL, Moon HH, Taichman RS, Van Poznak CH, Clines GA.

Neurosurgery. 2018 Dec 1;83(6):1306-1316. doi: 10.1093/neuros/nyx626.

PMID:
29462368
11.

Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature.

Singhal U, Wang Y, Henderson J, Niknafs YS, Qiao Y, Gursky A, Zaslavsky A, Chung JS, Smith DC, Karnes RJ, Chang SL, Feng FY, Palapattu GS, Taichman RS, Chinnaiyan AM, Tomlins SA, Morgan TM.

Mol Cancer Res. 2018 Apr;16(4):643-654. doi: 10.1158/1541-7786.MCR-17-0539. Epub 2018 Feb 16.

12.

CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes.

Jung Y, Cackowski FC, Yumoto K, Decker AM, Wang J, Kim JK, Lee E, Wang Y, Chung JS, Gursky AM, Krebsbach PH, Pienta KJ, Morgan TM, Taichman RS.

Cancer Res. 2018 Apr 15;78(8):2026-2039. doi: 10.1158/0008-5472.CAN-17-2332. Epub 2018 Feb 5.

13.

Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasis.

Hill EE, Kim JK, Jung Y, Neeley CK, Pienta KJ, Taichman RS, Nor JE, Baker JR Jr, Krebsbach PH.

J Cell Biochem. 2018 Nov;119(10):8074-8083. doi: 10.1002/jcb.26727. Epub 2018 Jun 22.

PMID:
29380900
14.

Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer.

Lee E, Wang J, Jung Y, Cackowski FC, Taichman RS.

J Cell Biochem. 2018 Apr;119(4):3697-3705. doi: 10.1002/jcb.26586. Epub 2018 Jan 9.

15.

Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.

Decker AM, Jung Y, Cackowski FC, Yumoto K, Wang J, Taichman RS.

Mol Cancer Res. 2017 Dec;15(12):1644-1655. doi: 10.1158/1541-7786.MCR-17-0132. Epub 2017 Aug 16.

16.

Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.

Shiozawa Y, Berry JE, Eber MR, Jung Y, Yumoto K, Cackowski FC, Yoon HJ, Parsana P, Mehra R, Wang J, McGee S, Lee E, Nagrath S, Pienta KJ, Taichman RS.

Oncotarget. 2017 Jun 6;8(23):38075. doi: 10.18632/oncotarget.18369. No abstract available.

17.

Clinical Assessment of Urinary Tract Damage during Sustained-Release Estrogen Supplementation in Mice.

Collins DE, Mulka KR, Hoenerhoff MJ, Taichman RS, Villano JS.

Comp Med. 2017 Feb 1;67(1):11-21.

18.

Dental Students', Alumni, and Dentists' Perspectives on Leadership: Impact of the Scholars Program in Dental Leadership.

Niemchick AL, Delgado J, Taichman RS, Inglehart MR.

J Dent Educ. 2017 Jan;81(1):44-53.

19.

Biochemical Changes in the Niche Following Tumor Cell Invasion.

Decker AM, Cackowski FC, Jung Y, Taichman RS.

J Cell Biochem. 2017 Aug;118(8):1956-1964. doi: 10.1002/jcb.25843. Epub 2017 Apr 18. Review.

20.

Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.

Yumoto K, Eber MR, Wang J, Cackowski FC, Decker AM, Lee E, Nobre AR, Aguirre-Ghiso JA, Jung Y, Taichman RS.

Sci Rep. 2016 Nov 7;6:36520. doi: 10.1038/srep36520.

21.

The role of hematopoietic stem cell niche in prostate cancer bone metastasis.

Decker AM, Jung Y, Cackowski F, Taichman RS.

J Bone Oncol. 2016 Feb 19;5(3):117-120. eCollection 2016 Sep.

22.

Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.

Cackowski FC, Eber MR, Rhee J, Decker AM, Yumoto K, Berry JE, Lee E, Shiozawa Y, Jung Y, Aguirre-Ghiso JA, Taichman RS.

J Cell Biochem. 2017 Apr;118(4):891-902. doi: 10.1002/jcb.25768. Epub 2016 Nov 10.

23.

DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.

Lee E, Wang J, Yumoto K, Jung Y, Cackowski FC, Decker AM, Li Y, Franceschi RT, Pienta KJ, Taichman RS.

Neoplasia. 2016 Sep;18(9):553-66. doi: 10.1016/j.neo.2016.07.007.

24.

The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.

Shiozawa Y, Berry JE, Eber MR, Jung Y, Yumoto K, Cackowski FC, Yoon HJ, Parsana P, Mehra R, Wang J, McGee S, Lee E, Nagrath S, Pienta KJ, Taichman RS.

Oncotarget. 2016 Jul 5;7(27):41217-41232. doi: 10.18632/oncotarget.9251. Erratum in: Oncotarget. 2017 Jun 6;8(23 ):38075.

25.

Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone Marrow.

Lee E, Decker AM, Cackowski FC, Kana LA, Yumoto K, Jung Y, Wang J, Buttitta L, Morgan TM, Taichman RS.

J Cell Biochem. 2016 Dec;117(12):2815-2824. doi: 10.1002/jcb.25582. Epub 2016 Sep 26.

26.

Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.

Jung Y, Decker AM, Wang J, Lee E, Kana LA, Yumoto K, Cackowski FC, Rhee J, Carmeliet P, Buttitta L, Morgan TM, Taichman RS.

Oncotarget. 2016 May 3;7(18):25698-711. doi: 10.18632/oncotarget.8365.

27.

Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer.

Qiao Y, Feng FY, Wang Y, Cao X, Han S, Wilder-Romans K, Navone NM, Logothetis C, Taichman RS, Keller ET, Palapattu GS, Alva AS, Smith DC, Tomlins SA, Chinnaiyan AM, Morgan TM.

Neoplasia. 2016 Jan;18(1):1-9. doi: 10.1016/j.neo.2015.11.009.

28.

The Role of Osteoclasts in Early Dissemination of Prostate Cancer Tumor Cells.

Zalucha JL, Jung Y, Joseph J, Wang J, Berry JE, Shiozawa Y, Taichman RS.

J Cancer Stem Cell Res. 2015;3. pii: e1005.

29.

Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors.

Shiozawa Y, Eber MR, Berry JE, Taichman RS.

Bonekey Rep. 2015 May 20;4:689. doi: 10.1038/bonekey.2015.57. eCollection 2015. Review.

30.

Tissue engineering a surrogate niche for metastatic cancer cells.

Seib FP, Berry JE, Shiozawa Y, Taichman RS, Kaplan DL.

Biomaterials. 2015 May;51:313-319. doi: 10.1016/j.biomaterials.2015.01.076. Epub 2015 Mar 4.

31.

Bone: Elucidating which cell erythropoietin targets in bone.

Shiozawa Y, Taichman RS.

Nat Rev Endocrinol. 2015 May;11(5):263-4. doi: 10.1038/nrendo.2015.32. Epub 2015 Mar 10. No abstract available.

PMID:
25752274
32.

Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling.

Li C, Shi C, Kim J, Chen Y, Ni S, Jiang L, Zheng C, Li D, Hou J, Taichman RS, Sun H.

J Dent Res. 2015 Mar;94(3):455-63. doi: 10.1177/0022034514566431. Epub 2015 Jan 13.

33.

Human bone marrow mesenchymal progenitors: perspectives on an optimized in vitro manipulation.

Cordeiro-Spinetti E, de Mello W, Trindade LS, Taub DD, Taichman RS, Balduino A.

Front Cell Dev Biol. 2014 Mar 27;2:7. doi: 10.3389/fcell.2014.00007. eCollection 2014. Review.

34.

The bone marrow endosteal niche: how far from the surface?

Cordeiro-Spinetti E, Taichman RS, Balduino A.

J Cell Biochem. 2015 Jan;116(1):6-11. doi: 10.1002/jcb.24952.

35.

Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow.

Jung Y, Wang J, Lee E, McGee S, Berry JE, Yumoto K, Dai J, Keller ET, Shiozawa Y, Taichman RS.

Mol Cancer Res. 2015 Jan;13(1):197-207. doi: 10.1158/1541-7786.MCR-14-0118. Epub 2014 Aug 19.

36.

Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells.

Krishnamurthy S, Warner KA, Dong Z, Imai A, Nör C, Ward BB, Helman JI, Taichman RS, Bellile EL, McCauley LK, Polverini PJ, Prince ME, Wicha MS, Nör JE.

Stem Cells. 2014 Nov;32(11):2845-57. doi: 10.1002/stem.1793.

37.

HSCs and niche relations marked by CD166.

Shiozawa Y, Taichman RS.

Blood. 2014 Jul 24;124(4):471-2. doi: 10.1182/blood-2014-04-571638. No abstract available.

PMID:
25061166
38.

Dentists' leadership-related educational experiences, attitudes, and past and current behavior.

Taichman LS, Taichman RS, Inglehart MR.

J Dent Educ. 2014 Jun;78(6):876-85.

39.

Expanding the scholarship on leadership training in dental education.

Taichman RS.

J Dent Educ. 2014 Jun;78(6):811-2. No abstract available.

40.

Megakaryocytes are mechanically responsive and influence osteoblast proliferation and differentiation.

Soves CP, Miller JD, Begun DL, Taichman RS, Hankenson KD, Goldstein SA.

Bone. 2014 Sep;66:111-20. doi: 10.1016/j.bone.2014.05.015. Epub 2014 Jun 2.

41.

Probing the CXCR6/CXCL16 Axis: Targeting Prevention of Prostate Cancer Metastasis.

Hershberger PM, Peddibhotla S, Sugarman E, Maloney P, Key D, Suyama E, Nguyen K, Vasile S, Kraft M, Stonich D, Mangravita-Novo A, Vicchiarelli M, Gosalia P, Milewski M, Li L, Hedrick M, Sun Q, Sergienko E, Cheltsov A, Salanawil S, Diwan J, Smith LH, Taichman RS, Chung TDY, Pinkerton AB, Malany S, Roth GP.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Dec 15 [updated 2014 May 13].

42.

Molecular pathways: niches in metastatic dormancy.

Yumoto K, Eber MR, Berry JE, Taichman RS, Shiozawa Y.

Clin Cancer Res. 2014 Jul 1;20(13):3384-9. doi: 10.1158/1078-0432.CCR-13-0897. Epub 2014 Apr 22. Review.

43.

Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering.

Yang KR, Mooney SM, Zarif JC, Coffey DS, Taichman RS, Pienta KJ.

J Cell Biochem. 2014 Sep;115(9):1478-85. doi: 10.1002/jcb.24813.

44.

A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD.

Yumoto K, Berry JE, Taichman RS, Shiozawa Y.

Cytometry A. 2014 Jun;85(6):548-55. doi: 10.1002/cyto.a.22434. Epub 2014 Apr 3.

45.

Human and murine very small embryonic-like cells represent multipotent tissue progenitors, in vitro and in vivo.

Havens AM, Sun H, Shiozawa Y, Jung Y, Wang J, Mishra A, Jiang Y, O'Neill DW, Krebsbach PH, Rodgerson DO, Taichman RS.

Stem Cells Dev. 2014 Apr 1;23(7):689-701. doi: 10.1089/scd.2013.0362. Epub 2014 Feb 4.

46.

TAM macrophages promote growth and metastasis within the cancer ecosystem.

Zarif JC, Taichman RS, Pienta KJ.

Oncoimmunology. 2014 Jul 3;3(7):e941734. eCollection 2014.

47.

Dentists' leadership-related perceptions, values, experiences and behavior: results of a national survey.

Forest AE, Taichman RS, Inglehart MR.

J Am Dent Assoc. 2013 Dec;144(12):1397-405.

PMID:
24282270
48.

Developing the next generation of leaders in oral health.

Kalenderian E, Taichman RS, Skoulas A, Nadershahi N, Victoroff KZ.

J Dent Educ. 2013 Nov;77(11):1508-14.

49.

The cancer diaspora: Metastasis beyond the seed and soil hypothesis.

Pienta KJ, Robertson BA, Coffey DS, Taichman RS.

Clin Cancer Res. 2013 Nov 1;19(21):5849-55. doi: 10.1158/1078-0432.CCR-13-2158. Epub 2013 Oct 7. Review.

50.

TBK1 regulates prostate cancer dormancy through mTOR inhibition.

Kim JK, Jung Y, Wang J, Joseph J, Mishra A, Hill EE, Krebsbach PH, Pienta KJ, Shiozawa Y, Taichman RS.

Neoplasia. 2013 Sep;15(9):1064-74.

Supplemental Content

Loading ...
Support Center